ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.

Highlights Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

Equities

603168

CNE100001TG0

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 02/07/2024 am IST			5-day change	1st Jan Change
7.37 ^CNY	+0.27%		-1.86%	-45.04%

29/04	Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
19/04	Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	19/04	CI
Shapuaisi Pharma Gets Marketing Authorization for Moxifloxacin Hydrochloride Eye Drops	09/04	MT
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	13/23/13	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
Shanghai Lechun Biotechnology Co., Ltd. sign a share transfer agreement to acquire a 14.5% stake in Advanced Sterile Solutions Biotechnology Co., Ltd. from Shanghai Changgeng Industrial Development Co., Ltd. and Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. for CNY 40.6 million.	09/23/09	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. agreed to acquire Qingdao Shikang Eye Hospital Co., Ltd. from Shanghai Fangzhi Medical Management Co., Ltd. for CNY 66.5 million	04/23/04	CI
Zhejiang Shapuaisi Pharma Shareholder Boosts Stake Through $44 Million Deal	10/22/10	MT
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/22/28	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/22/29	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	25/22/25	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	29/21/29	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	30/21/30	CI
Shanghai Tonghui Medical Management Co., Ltd. completed the acquisition of 5.43% stake in Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. from Chen Dekang.	20/21/20	CI
Shanghai Tonghui Medical Management Co., Ltd. signed a share transfer agreement to acquire 5.43% stake in Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. from Chen Dekang for approximately CNY 400 million.	07/21/07	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	19/21/19	CI
Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. signed an agreement to acquire Shapuaisi Qiangshen Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. for CNY 82 million.	10/21/10	CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	28/20/28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

Equities

603168

CNE100001TG0

Highlights

Filters